Authorized purpose: EchoPAC Software Only and Plug-in provide diagnostic review, analysis, recording, and reporting functions for ultrasound images, including raw GE and DICOM ultrasound data.
Clinical role
EchoPAC Software Only and Plug-in provide diagnostic review, analysis, recording, and reporting functions for ultrasound images, including raw GE and DICOM ultrasound data.
Images and patients
Ultrasound · Whole body and anatomy represented in the labeled ultrasound applications
Key limitation
Keep in mind: Applicability depends on supported ultrasound data, installed plug-in configuration, patient, anatomy, and professional interpretation.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: EchoPAC Software Only and Plug-in provide diagnostic review, analysis, recording, and reporting functions for ultrasound images, including raw GE and DICOM ultrasound data.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Whole body and anatomy represented in the labeled ultrasound applications Input: Ultrasound echo data acquired with the supported transducers, exam modes, and labeled patient or anatomy scope.
Who uses it?Intended users: Qualified healthcare professionals within the exact labeled use.
What does the software produce?Output: Ultrasound images, measurements, flow information, or clinician-reviewed analyses described in the exact FDA labeling.
What is its most important limitation?Key limitation: Applicability depends on supported ultrasound data, installed plug-in configuration, patient, anatomy, and professional interpretation.
Clinical takeaway. Clinical role: EchoPAC Software Only and Plug-in provide diagnostic review, analysis, recording, and reporting functions for ultrasound images, including raw GE and DICOM ultrasound data.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports voluntary standards conformance and AI Auto Doppler testing on 4106 Tissue Doppler recordings from 805 individuals and 3390 Doppler Trace recordings from 1369 individuals from independent institutions, with ground truth annotations by two cardiologists. All clinical parameters measured by AI Cardiac Auto Doppler without user edits met the accuracy acceptance criteria. Clinical studies were not required. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
EchoPAC Software Only and Plug-in provide diagnostic review, analysis, recording, and reporting functions for ultrasound images, including raw GE and DICOM ultrasound data.
EchoPAC Software Only and Plug-in provide diagnostic review, analysis, recording, and reporting functions for ultrasound images, including raw GE and DICOM ultrasound data.
The exact FDA document reports voluntary standards conformance and AI Auto Doppler testing on 4106 Tissue Doppler recordings from 805 individuals and 3390 Doppler Trace recordings from 1369 individuals from independent institutions, with ground truth annotations by two cardiologists. All clinical parameters measured by AI Cardiac Auto Doppler without user edits met the accuracy acceptance criteria. Clinical studies were not required. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The EchoPAC Software Only / EchoPAC Plug-in complies with voluntary standards:" … "Tissue Doppler testing dataset included 4106 recordings from 805 individuals. • Doppler Trace testing dataset included 3390 recordings from 1369 individuals.". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports voluntary standards conformance and AI Auto Doppler testing on 4106 Tissue Doppler recordings from 805 individuals and 3390 Doppler Trace recordings from 1369 individuals from independent institutions, with ground truth annotations by two cardiologists. All clinical parameters measured by AI Cardiac Auto Doppler without user edits met the accuracy acceptance criteria. Clinical studies were not required. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "The EchoPAC Software Only / EchoPAC Plug-in complies with voluntary standards:" … "Tissue Doppler testing dataset included 4106 recordings from 805 individuals. • Doppler Trace testing dataset included 3390 recordings from 1369 individuals.". Read from the exact FDA decision document on 2026-11-14.
No exact-product, version-specific sensitivity endpoint was established for this submission in the evidence set.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No exact-product, version-specific specificity endpoint was established for this submission in the evidence set.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K251342 FDA evidence package for EchoPAC Software Only / EchoPAC Plug-in
DesignFDA submission-level decision material with device, software, performance, safety, and/or usability verification as applicable; not independent clinical validation.
PopulationPopulation and workflow are limited to the exact FDA labeling summarized for this submission.
Scopeexact submission
Tested versionExact FDA submission release; version not separately stated in the public decision material
IndependenceSponsor or vendor study
K251342
Evidence submitted for the exact FDA decision is not independent clinical validation. Local technical, clinical, privacy, security, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K251342 by native exact submission identifier. This does not exclude product-family, later, or adverse-event information.
Public source
Exact FDA submission
Checked 2026-09-04
Exact-identifier review does not prove absence of all product-family safety signals.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, dental, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Ultrasound echo data acquired with the supported transducers, exam modes, and labeled patient or anatomy scope.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM-compliant transfer through a LAN between systems, devices, file servers, and workstations is described; local round-trip and archive testing remain necessary.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes EchoPAC Software Only as software installed directly on customer PC hardware and EchoPAC Plug-in as hosted by a generalized PACS host workstation, with a cloud-based licensing system for shared virtual licenses. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "EchoPAC Software Only will be offered as SW only to be installed directly on customer PC hardware and EchoPAC Plug-in is intended to be hosted by a generalized PACS host workstation." … "SW Based Licensing: Cloud-based licensing system, allowing customers to use shared virtual licenses which removes the need for the physical USB license dongles.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Ultrasound images, measurements, flow information, or clinician-reviewed analyses described in the exact FDA labeling.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Ultrasound images, measurements, flow information, or clinician-reviewed analyses described in the exact FDA labeling.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes EchoPAC Software Only as software installed directly on customer PC hardware and EchoPAC Plug-in as hosted by a generalized PACS host workstation, with a cloud-based licensing system for shared virtual licenses. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "EchoPAC Software Only will be offered as SW only to be installed directly on customer PC hardware and EchoPAC Plug-in is intended to be hosted by a generalized PACS host workstation." … "SW Based Licensing: Cloud-based licensing system, allowing customers to use shared virtual licenses which removes the need for the physical USB license dongles.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
DICOM-compliant transfer through a LAN between systems, devices, file servers, and workstations is described; local round-trip and archive testing remain necessary.
GE HealthCare's Product Security Portal is described as a credentialed global portal giving customers security updates, vulnerability status and required actions for GE HealthCare products potentially impacted by critical vulnerabilities, plus historical patch views; GE HealthCare references its Cybersecurity Risk Management System and publishes a Coordinated Vulnerability Disclosure Statement for reporting vulnerabilities in GE HealthCare products.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: GE HealthCare's own Privacy Shield page on gehealthcare.com names GE Medical Systems, Ultrasound & Primary Care Diagnostics LLC as a US entity of the GEHC group. Corporate program statement; portal content is credentialed; exact-release scope is not established.
Use by the qualified healthcare professionals identified for the exact labeled workflow; site-specific competency and training requirements remain to be established locally.
GE HealthCare's product security page states that it provides a credentialed Product Security Portal offering security updates, vulnerability status and actions, and patch views for GE HealthCare products under its Cybersecurity Risk Management System, and links its Coordinated Vulnerability Disclosure Statement.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The page names GE HealthCare generally and does not scope these commitments to any specific product release; exact-release scope is not established. Portal access is credentialed; contents were not read.
DICOM-compliant transfer through a LAN between systems, devices, file servers, and workstations is described; local round-trip and archive testing remain necessary.
exact submission · checked 2026-09-04
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Applicability depends on supported ultrasound data, installed plug-in configuration, patient, anatomy, and professional interpretation.
exact submission · checked 2026-09-04
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04
No exact-product price was found in the evidence set; productivity or value claims require local evidence.
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes; exact monitoring thresholds and vendor commitments are unknown.
exact submission · checked 2026-09-04
Establish ownership for data quality, overrides, drift, incidents, recalls, and change control.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-20Last searched
27Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public list price for the exact cleared configuration was found in the evidence set. Obtain a written quote covering license or hardware basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, downtime, and exit costs.
Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.
Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Authorized purpose: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.
Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.